News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Materiales de laboratorio
Solve your sustainability challenge
Healthcare · Industrial biotechnology
Dos científicas trabajando en un laboratorio
Vaxdyn and the University of Latvia have obtained funding from the EUROSTARS program to prepare prevention strategies for diseases caused by antibiotic-resistant bacteria.
Healthcare · Access to innovation · Advanced therapies
They receive a grant of half a million euros to prepare the clinical and commercial strategy for…
Partners - Vaxdyn
Un científico analiza una muestra en un microscopio
The R&D investment of Spanish biotechnology increased by 13% in 2022, surpassing 2.5 billion euros
Agrifood · Food & feed · Agriculture · Animal health · Financing · Services · Talento
According to the INE, when exclusively analyzing the figures in Companies, R&D investment has…
Foto de Francisco Miguel Torres, Partnerships Director, Southern Europe de OWKIN
#NewAseBioMember | “AseBio is an important industry association in Spain, representing the interests of companies, associations, foundations and universities in the bioindustry”
Healthcare · Digitalization · Corporate
Meet Owkin, our new member. We talked to its Francisco Miguel Torres, Partnerships Director,…
AseBio - OWKIN
foto_recurso_pastillas
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopardizes biotechnological innovation if improvements are not introduced
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies · Antibiotic resistance
Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in…
foto_recurso_parkinson
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative disease
Healthcare · Access to innovation · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications…
Spinally
#NewAseBioMember | “AseBio represents a platform within the bioindustry ecosystem”
Healthcare · Corporate
Meet Spinally Medical, our new member. We talked to its Carles García-Vitoria, Co-fundador &…
Mercedes_Iriarte_Cela
#NewAseBioMember | “AseBio is the perfect platform for company collaboration, research synergies, agreements and potential investment”
Healthcare · Corporate
Meet Copal Scientific, our new member. We talked to its Mercedes Iriarte Cela, CEO.
células foto oryzon
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by NCI for iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer
Healthcare · Access to innovation
In combination with either atezolizumab or durvalumab. 
Partners - Oryzon Genomics